TAUOPATHIES
Clinical trials for TAUOPATHIES explained in plain language.
Never miss a new study
Get alerted when new TAUOPATHIES trials appear
Sign up with your email to follow new studies for TAUOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new drug to slow Alzheimer's progression
Disease control Recruiting nowThis study is testing whether the drug donanemab is safe and effective at slowing the progression of early Alzheimer's disease. It will involve about 1,500 people who have mild memory problems and confirmed Alzheimer's-related brain changes. Participants will receive either the d…
Matched conditions: TAUOPATHIES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New brain scan aims to sharpen picture of Alzheimer's disease
Diagnosis Recruiting nowThis study is testing a new type of brain scan designed to better see and measure a harmful protein called tau, which builds up in diseases like Alzheimer's. Researchers will give a small, safe amount of a radioactive tracer to about 20 participants, including healthy people and …
Matched conditions: TAUOPATHIES
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Mar 12, 2026 13:51 UTC
-
Scientists test new brain scan to see hidden protein clumps
Knowledge-focused Recruiting nowThis study is testing a new imaging tracer to see if it can safely highlight clumps of a specific protein called tau in the brain. Researchers will give the tracer to 90 people, including those with conditions like Progressive Supranuclear Palsy, Alzheimer's, and Parkinson's, as …
Matched conditions: TAUOPATHIES
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
New brain scan seeks clues to devastating neurological diseases
Knowledge-focused Recruiting nowThis study aims to test a new radioactive tracer for brain scans to see if it can detect and measure a specific abnormal protein linked to Multiple System Atrophy (MSA). Researchers will compare brain images from 70 people, including those with MSA, Parkinson's disease, Progressi…
Matched conditions: TAUOPATHIES
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists hunt for better brain disease scans
Knowledge-focused Recruiting nowThis study aims to test and improve new brain imaging techniques (PET scans) to better detect specific proteins linked to several neurological diseases, including Parkinson's disease and certain dementias. Researchers will enroll about 94 participants, including people with these…
Matched conditions: TAUOPATHIES
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC